Insmed (INSM) – Press Releases
-
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
Insmed to Present New Data from Across its Respiratory Portfolio at the American Thoracic Society 2024 International Conference
-
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
Insmed To Present at Three March Conferences
-
Actress Jane Seymour and Insmed Raise Awareness of "Unseenism" and Empower People to Speak Up When It Comes to Their Health
-
Insmed Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Business Update
-
Insmed to Host Fourth-Quarter and Full Year 2023 Financial Results Conference Call on Thursday, February 22, 2024
-
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
Insmed Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference
-
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
Insmed To Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
Insmed To Present at the Nasdaq 49th Investor Conference
-
Insmed To Present at Two November Conferences
-
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
Insmed Holds Second Annual Global Day of Good to Benefit Communities Across the Globe
-
Insmed Ranks No. 1 on Science's 2023 Top Biopharma Employers List
-
Insmed Reports Third-Quarter 2023 Financial Results and Provides Business Update
-
Insmed and Google Cloud Collaborate to Transform the Lives of Patients by Harnessing the Power of AI
-
Insmed to Host Third-Quarter 2023 Financial Results Conference Call on Thursday, October 26, 2023
-
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
Insmed To Present at Chardan's 7th Annual Genetic Medicines Conference
-
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
Insmed To Present at the Morgan Stanley 21st Annual Global Healthcare Conference
-
INSMED ANNOUNCES POSITIVE TOPLINE RESULTS FROM PHASE 3 ARISE STUDY OF ARIKAYCE® (AMIKACIN LIPOSOME INHALATION SUSPENSION) IN PATIENTS WITH NTM LUNG DISEASE CAUSED BY MAC
-
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
Insmed Reports Second-Quarter 2023 Financial Results and Provides Business Update
-
Insmed to Host Second-Quarter 2023 Financial Results Conference Call on Thursday, August 3, 2023
-
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
Insmed To Present at the Goldman Sachs 44th Annual Global Healthcare Conference
-
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
Insmed Presents Range of New Study Findings at American Thoracic Society 2023 International Conference
-
Insmed Unveils New Research Platforms and Capabilities at Investor and Analyst Event, "The Future of Rare at Insmed: Functional Genes, AI-Enhanced Proteins, Glowing Algae, and More"
-
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
Insmed Reports First Quarter 2023 Financial Results and Provides Business Update
-
Insmed to Host Investor and Analyst Event on May 8, 2023
-
Insmed to Host First Quarter 2023 Financial Results Conference Call on Thursday, May 4, 2023
-
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
Insmed Completes Enrollment of Adult Patients in Phase 3 ASPEN Study of Brensocatib in Bronchiectasis
-
Insmed to Present New Clinical, Pre-Clinical, and Real-World Data in Serious and Rare Lung Diseases at the American Thoracic Society 2023 International Conference
-
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
Insmed To Present at Two March Conferences
-
Insmed Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
-
Insmed to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call on Thursday, February 23, 2023
-
Insmed To Present at the SVB Securities Global Biopharma Conference
-
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
Analysts and Executives Converge February 2nd at the 30th Annual Emerald Groundhog Day Investment Forum
-
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
Insmed Provides Business Updates and Near-Term Strategic Outlook at 41st Annual J.P. Morgan Healthcare Conference
-
Insmed To Present at the 41st Annual J.P. Morgan Healthcare Conference
Back to INSM Stock Lookup
